DCF — FREMONT HEALTH
Enterprise Value: $69.9M
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$69.9M
Enterprise Value
$17.3M
PV of Cash Flows
$52.6M
PV of Terminal Value
$84.8M
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $133.9M | $10.1M | 8.0% | $2.8M | $2.5M |
| Year 2 | $137.9M | $11.8M | 9.0% | $3.9M | $3.2M |
| Year 3 | $142.0M | $13.6M | 10.0% | $5.0M | $3.8M |
| Year 4 | $146.3M | $14.7M | 10.0% | $5.7M | $3.9M |
| Year 5 | $150.7M | $15.5M | 10.0% | $6.2M | $3.9M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $69.9M. Terminal value accounts for 75% of total EV — typical range (60-80%).
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$130.0M
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base0.07050625889594153
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5